Please use this identifier to cite or link to this item: http://dulieuso.hmu.edu.vn/handle/hmu/3093
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorVũ Văn, Giáp-
dc.contributor.advisorNguyễn Hữu, Ước-
dc.contributor.authorVũ Văn, Thời-
dc.date.accessioned2021-12-15T04:03:37Z-
dc.date.available2021-12-15T04:03:37Z-
dc.date.issued2021-
dc.identifier.urihttp://dulieuso.hmu.edu.vn/handle/hmu/3093-
dc.description.abstractOver the past years, lung transplantation has become a viable treatment option for patients with a variety of end-stage lung diseases. The first human lung transplant procedure was performed in 1963, and the recipient survived 18 days, ultimately succumbing to renal failure and malnutrition1. Despite the outcome, this demonstrated that lung transplantation was technically feasible and that rejection could be averted with the available immunosuppressive agents, at least for a short time.Over the ensuing 15 years, few lung transplant procedures were performed, and the majority of recipients died perioperatively because of bronchial anastomotic complications. However, in 1981, the first successful heart-lung transplantation was performed for idiopathic pulmonary arterial hypertension2. This was followed in 1983 by the first successful single lung transplantation for idiopathic pulmonary fibrosis3 and in 1986 by the first double lung transplantation for emphysema4. These successes were attributed to improved surgical techniques and the advent of cyclosporine. Over the following several years, the number of lung transplant procedures performed rapidly increased. As reported by ISHLT, there were about 4554 adult lung transplants in 20165. Although advances in patient selection, organ preservation, surgical technique, immunosuppression, and postoperative intensive care have improved overall survival following lung transplantation, the mortality associated with post-lung transplantation airway complications remains between 2% and 4%6. Although this is a low attributable mortality, overall survival rates are reduced at 30 days, 90 days, 1 year, 3 years, and 5 years in lung transplant recipients experiencing airway complications. In Vietnam, in recent years following the success of state and ministerial level projects on kidney transplants, liver transplants, and heart transplants, many organ transplant centers in the country have paid attention to developing heart-lung transplantation and lung transplant. Through several empirical studies, it has had applications in humans such as "heart-lung transplant" from a brain-dead donor in Hue Central Hospital (July 20, 2015), "bilateral lung transplants from two living donors." for 7 years old patients with cystic fibrosis at 103 Military Medical University Hospital (February 21, 2017)," bilateral lung transplants from brain-dead donor "at 108 Military Central Hospital for diseases Patients with chronic obstructive pulmonary disease (February 26, 2018). Especially from December 2018 until now, Viet Duc Hospital has successfully performed 5 lung transplants from brain-dead donors. In the success of lung transplants, we also have a lot of difficulties in airway complications post-lung transplant. However, there are no research topics on this issue so we perform the research: “Surveillance bronchoscopy in diagnosis and management of complications post lung transplantation”. Objective: 1. To describe the characteristic of complications post lung transplantation. 2. To evaluate the efficacy and the safety of bronchoscopy in the management of complications post lung transplantation.vi_VN
dc.description.tableofcontentsINTRODUCTION 1 CHAPTER 1 3 REVIEW LITERATURE 3 1.1. Lung transplantation: An overview 3 1.1.1. Definitions 3 1.1.2. Types of lung transplantation 3 1.1.3. Indications general 4 1.1.4. Contraindications 5 1.2. The role of bronchoscopy post lung transplantation 6 1.2.1. Surveillance bronchoscopy versus clinically mandated 6 1.2.2. Diagnosis of infections 7 1.2.3. Diagnosis of acute cellular rejection 7 1.2.4. Diagnosis of antibody mediated rejection 8 1.2.5. Diagnosis and management of airway complications 9 CHAPTER 2 27 MATERIAL AND METHODS 27 2.1. Study population 27 2.2. Work plan/Timeline 27 2.3. Material 27 2.3.1. Inclusion criteria: 27 2.3.2. Exclusion criteria: 27 2.3.3. Diagnostic criteria and classifications airway complications 27 2.3.4. Study design 30 2.3.5. Sample size 30 2.3.6. Study variables and data collection 30 2.3.7. Data processing 31 2.3.8. Errors, interference and remedies. 31 2.3.9. Ethics in study 32 CHAPTER 3 33 OBSERVATION AND RESULTS 33 3.1. The general distribution of study 35 3.1.1. Age and sex distribution 35 3.1.2. Clinical characteristics pre-transplant. 35 3.1.3. Laboratory characteristics pre-transplant. 36 3.1.4 Diagnosis and surgery characteristics 38 3.2. Describe the characteristics of complications post-lung transplantation. 39 3.2.1. Infections characteristics 39 3.2.2. Airway complications characteristics 41 3.2.3. Acute cellular rejection (ACR) and Antibody-mediated rejection (AMR) characteristics 42 3.3. Evaluate the efficacy and the safety of bronchoscopy in management of airway complications post lung transplantation 43 3.3.1 Evaluate the efficacy of bronchoscopy in management of airway complications 43 3.3.2. Complications 44 CHAPTER 4 45 DISCUSSION 45 4.1 General characteristics 45 4.1.1 Age, sex 45 4.1.2 Clinical characteristics pre-transplant. 46 4.1.3. Laboratory characteristics pre-transplant 48 4.1.4 Diagnosis and surgery characteristics 49 4.2 Describe the characteristics of complications post-lung transplantation. 50 4.2.1 Infection characteristics 50 4.2.2 Airway complications characteristics 51 4.2.3 Acute cellular rejection (ACR) and Antibody-mediated rejection (AMR) characteristics 58 4.3 Evaluate the efficacy and the safety of bronchoscopy in management of airway complications post lung transplantation. 61 4.3.1 The efficacy of bronchoscopy in management of airway complications post lung transplantation 61 4.3.2 Complications 64 CONCLUSION 66 1. Describe the characteristics of complications post lung transplantation. 66 2. Evaluate the efficacy and the safety of bronchoscopy in management of airway complications post lung transplantation. 66 REFERENCES 68 APPENDIX 76vi_VN
dc.language.isovivi_VN
dc.subjectNội khoavi_VN
dc.subject8720107vi_VN
dc.titleSurveillance bronchoscopy in diagnosis and management of complications post lung transplantationvi_VN
dc.typeThesisvi_VN
Appears in Collections:Luận văn thạc sĩ

Files in This Item:
File Description SizeFormat 
2021THSvuvanthoi.docx
  Restricted Access
4.39 MBMicrosoft Word XML
2021THSvuvanthoi.pdf
  Restricted Access
1.08 MBAdobe PDFbook.png
 Sign in to read


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.